INVITRO SUSCEPTIBILITY OF PSEUDOMONAS-AERUGINOSA FROM BACTEREMIC AND FIBROCYSTIC PATIENTS TO 4 QUINOLONES AND 5 OTHER ANTIPSEUDOMONAL ANTIBIOTICS

被引:5
作者
LESTER, A [1 ]
ANDREASEN, JJ [1 ]
机构
[1] STATENS SERUM INST,DEPT ANTIBIOT,DK-2300 COPENHAGEN S,DENMARK
关键词
D O I
10.3109/00365548809032501
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:525 / 529
页数:5
相关论文
共 15 条
[11]  
SCULLY BE, 1986, LANCET, V1, P819
[12]   CEFTAZIDIME ALONE FOR TREATING PSEUDOMONAS-AERUGINOSA SEPTICEMIA IN NEUTROPENIC PATIENTS [J].
VERHAGEN, C ;
DEPAUW, BE ;
DONNELLY, JP ;
WILLIAMS, KJ ;
DEWITTE, T ;
JANSSEN, JTP .
JOURNAL OF INFECTION, 1986, 13 (02) :125-131
[13]   INVITRO ACTIVITY OF CARUMONAM (RO 17-2301) AND 12 OTHER ANTIMICROBIALS AGAINST CLINICAL ISOLATES OF PSEUDOMONAS-AERUGINOSA [J].
VURMARAPP, U ;
KAYSER, FH .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1986, 5 (03) :292-296
[14]   THE FLUOROQUINOLONES - STRUCTURES, MECHANISMS OF ACTION AND RESISTANCE, AND SPECTRA OF ACTIVITY INVITRO [J].
WOLFSON, JS ;
HOOPER, DC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (04) :581-586
[15]  
1981, SCAND J INFECT DIS, V13, P148